Update on Titan Dispute

By

Regulatory News | 19 Sep, 2024

Updated : 14:47

RNS Number : 9264E
Tavistock Investments PLC
19 September 2024
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

Tavistock Investments Plc

("Tavistock" or the "Company")

 

Update on Titan Dispute

 

19 September 2024

 

Further to the announcements released by the Company on 8 July 2024 and 11 July 2024, Tavistock today announces that it has received notification that Titan Wealth Holdings Limited ("Titan") has issued a claim against the Company in the High Court.

 

Tavistock is confident that the claim has no merit and considers it to be a vexatious and retaliatory step following Tavistock's termination of its 10-year strategic partnership with Titan, as announced on 8 July 2024. That termination was as a result of several breaches of contract and sustained unacceptable fund performance (as further detailed in Tavistock's 'Follow up to Titan termination announcement' issued on 11 July 2024 - performance table repeated below).

 

Tavistock believes that this claim by Titan is an opportunistic and spurious attempt to frustrate the Company's genuine claim for damages which is currently being progressed by the Company's legal representatives.

 

Tavistock's Chief Executive, Brian Raven, commented:

 

"Titan's claim is notable for its lack of evidence and much of what it alleges is factually inaccurate. It will be refuted, and our damages claim pursued in due course."

 

  

Performance post Titan's breaches of contract (27th Aug 2022 - 4th Jan 2024)


Performance vs Benchmark

Quartile Rank

Fund Rank

Percentile Rank

ACUMEN Portfolio 4

-7.89%

4th

176/177

100th

ACUMEN Portfolio 5

-8.27%

4th

177/177

100th

ACUMEN Portfolio 6

-9.72%

4th

212/215

99th

ACUMEN Portfolio 7

-11.19%

4th

214/215

100th

ACUMEN Portfolio 8

-13.51%

4th

157/159

99th

Average

-10.12%

4th

 

100th

     

      Source of data: FE Analytics

 

For further information:

 


Tavistock Investments Plc

Oliver Cooke

Brian Raven

 

Tel: 01753 867000



Allenby Capital Limited

(Nominated adviser and broker)

Corporate Finance:

Nick Naylor, Liz Kirchner, Daniel Dearden-Williams

Sales and Corporate Broking:

Tony Quirke

 

Tel: 020 3328 5656



Infinite Global

(PR adviser)

Ryan McSharry

Matthew Gilleard

 

Tel: 0207 269 1430

       07860 534 141


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFSVARIALIS

Last news